
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Thymidine Kinase CRISPR/Cas9 KO Plasmid (m) | sc-423409 | 20 µg | $397.00 | |||
Thymidine Kinase HDR Plasmid (m) | sc-423409-HDR | 20 µg | $445.00 |
Tk1 encodes thymidine kinase 1, a cytosolic, S-phase–regulated enzyme that catalyzes phosphorylation of thymidine in the pyrimidine salvage pathway to support dTTP production during DNA replication and repair. TK1 activity is tightly coupled to cell-cycle progression and nucleotide pool homeostasis, linking it to DNA synthesis, replication stress responses, and genome stability. Altered TK1 expression and activity are frequently associated with proliferative states and dysregulated cell-cycle control, making Tk1 a useful node for studying mechanisms that couple nucleotide metabolism to growth signaling. In mouse systems, Tk1 perturbation enables functional interrogation of cell proliferation programs in development, tissue regeneration, and models of oncogenic transformation without implying clinical utility.
Thymidine Kinase CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Tk1 gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Tk1 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, Thymidine Kinase HDR Plasmid (m) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Tk1 target site.
When co-transfected with Thymidine Kinase CRISPR/Cas9 KO Plasmid (m):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Tk1 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.